Ads
related to: novartis pharmaceuticals stock newsdirexion.com has been visited by 10K+ users in the past month
- Bull & Bear 3X ETFs
Fixed Income, International Equity
Market Cap And Sector Equity
- Healthcare ETF
Direxion Daily Healthcare ETF
Bull 3X Shares ETF - CURE
- Education
Articles, videos & tools to help
understand Leveraged ETFs and more.
- ETF Line-up
View Direxion's Complete List of
Leveraged and Inverse ETFs.
- Bull & Bear 3X ETFs
Search results
The Zacks Analyst Blog Highlights Regeneron Pharmaceuticals, Merck, Novartis and AstraZeneca
Zacks via Yahoo Finance· 9 months agoFor Immediate Release Chicago, IL – August 29, 2023 – Zacks.com announces the list of stocks...
The Zacks Analyst Blog Highlights Procter & Gamble, Novartis, Mondelez International, Elevance...
Zacks via Yahoo Finance· 6 months agoFor Immediate Release Chicago, IL – November 21, 2023 – Zacks.com announces the list of stocks...
Biotech Stocks Heat Up As Arvinas Scores Novartis Licensing Pact, Janux Reportedly Explores Options
Investor's Business Daily· 2 months agoBiotech stocks heated up Thursday, driven by a spate of deals, as Novartis scooped up a licensing...
Drug Maker Novartis Stock Shows Rising Relative Strength
Investor's Business Daily· 10 months agoNovartis stock had its Relative Strength (RS) Rating upgraded from 69 to 73 Monday -- a welcome...
Novartis deepens ties with Voyager via $100M gene therapy deal
BioPharma Dive via Yahoo Finance· 5 months agoDive Brief: Swiss pharmaceutical company Novartis has formed a new collaboration with partner...
The Zacks Analyst Blog Highlights J&J, Novartis, GSK, Merck and AbbVie
Zacks via Yahoo Finance· 2 years agoFor Immediate Release Chicago, IL – July 25, 2022 – Zacks.com announces the list of stocks featured...
Novartis raises forecasts as top drug sales beat Wall Street estimates
BioPharma Dive via Yahoo Finance· 1 month agoSales of Novartis drugs for heart failure, psoriasis and multiple sclerosis were stronger over the...
Why Big Pharma Is Following Novartis' Lead In A $25 Billion Market
Investor's Business Daily· 1 month agoNovartis blazed a trail for treating cancer with targeted radiopharmaceuticals, a treatment that...
Could This Medicine Be the Next Winner for Novartis?
Motley Fool· 9 months agoEarlier this month, the Switzerland-based pharmaceutical Novartis (NYSE: NVS) shared encouraging news from two phase 3 clinical trials of its drug...
Ionis Pharmaceuticals Nosedives After AstraZeneca Drops High Cholesterol Drug Test
Investor's Business Daily· 2 years agoIonis Pharmaceuticals stock tumbled Friday after partner AstraZeneca decided against sending the...